期刊文献+

中老年血清瘦素、脂联素、白介素-6及纤溶酶原激活物抑制物-1的流行病学调查 被引量:1

An epidemiologieal investigation on serum levels of leptin, adiponectin, interleukin-6 and plasminogen activator inhibitor-1 in middle aged and elderly people
下载PDF
导出
摘要 目的对广州市中老年人血清瘦素(1eptin)、脂联素(adiponectin)、白介素-6(interleukin~6,IL-6)及纤溶酶原激活物抑制物-1(plasminogen activator inhibitor-1,PAI-1)进行流行病学调查。方法在广州市生物库第三期注册登记的10027名中老年人中随机抽取1996名中老年人进行问卷调查和健康体检。以酶联免疫吸附双抗夹心(ELISA)法测定leptin、adiponectin、IL-6、PAI-1。结果广州市中老年人leptin、adiponectin、IL-6、PAI-1分别为(10.46±9.75)μg,L、(9115.5±9812.91)μg/L、(13.13±6.50)μg/mL和(163.71±110.04)μg/L。校正年龄因素后,男、女性别间leptin、adiponectin、IL-6和PAI-1差异均有显著性(P〈0.05)。结论本次大样本的中老年leptin、adiponectin、IL-6、PAI-1的流行病学调查数据可靠,为后期的生活方式号漫性心、脑血管和代谢性疾病关系的研究和公共卫生干预提供了依据。 Objective To conduct an epidemiological investigation on leptin, adiponectin, interleukin-6 ( IL-6 ), and plasminogen activator inhibitor-1 ( PAI-1 ) in the middle aged and elderly people in Guangzhou. Methods 1996 of 10 027 middle aged and elderly people registered at Guangzhou Database were randomly selected to be surveyed by questionnaires and to have physical examination. Levels of leptin, adiponectin, IL-6, and PAl-1 were determined by enzyme-linked immunosorbent assay (ELISA). Results Leptin was ( 10.46 ± 9.75 ) μg/L, adiponectin was ( 9115.5 ± 9812.91 ) μg/L, IL-6 was ( 13.13 ± 6.50 ) pg/mL, and PAI-1 was ( 163.71 ± 110.04 ) μg/L in Guangzhou middle aged and elderly people. There were significant differences in levels of leptin, adiponectin, IL-6, and PAl-1 between male and female after age adjustment. Conclusions Reliable data of leptin, adiponectin, IL-6, and PAl- 1 in this large-scale epidemiological investigation provides support for the future research on the relationship between lifestyle and chronic cardiovascular, cardiocerebrovascular diseases and metabolic disorders and for public health interventions.
出处 《国际医药卫生导报》 2012年第3期421-424,共4页 International Medicine and Health Guidance News
关键词 瘦素 脂联素 白介素-6 纤溶酶原激活物抑制物-1 ELISA方法 Leptin Adiponectin IL-6 PAI-1 ELISA
  • 相关文献

参考文献21

  • 1Sheng WH, Chiang BL, Chang SC, et al. Clinical manifeststions and inflammatory eytokine respenses in patients with severe acute respiatory syndrome[J]. J Formos Med Assoc, 2005, 104 ( 10): 715-723.
  • 2Zorio E, Gilabert-Estelles J, Espafla F, et al. Fibrinolysis: the key to new pathogenetic mechanisms [J]. Curr Med Chem, 2008, 15 ( 9 ): 923-929.
  • 3Bremer AA, Devaraj S, Afify A, et al. Adipose tissue dysreguIation in patients with metabolic syndrome[J].J Clin Endocrinol Metab, 2011,96( 11 ): E1782-E1788.
  • 4Vykoukal D, Davies MG. Vascular biology of metabolic syndrome[J].J Vase Surg, 2011, 54 ( 3 ): 819-831.
  • 5Gnacinska M, Ma korzewicz S, Guzek M, et al. Adipose tissue activity in relation to overweight or obesity[J]. Endokrynol Pol, 2010, 61 ( 2 ): 160-168.
  • 6周善存,罗进才,王少波,梁志丽,张煜,邓黎.代谢综合征大血管病变与PAI-1、hs—CRP水平及心脑血管危险因素相关性研究[J].国际医药卫生导报,2010,16(19):2322-2324. 被引量:2
  • 7Leung YM, Kwan CY. Dual vascular effects of leptin via endothelium: hypothesis and perspective[J]. Chin J Physiol, 2008, 51 (1): 1-6.
  • 8Abel ED, Litwin SE, Sweeney G. Cardiac remodeling in obesity[J]. Physiol Rev. 2008, 88 ( 2 ). 389-419.
  • 9Correia ML,Rahmouni K. Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome[J]. Diabetes Obes Metab, 2006,8( 6 ): 603- 610.
  • 10Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity[J]. Biochem Biophys Res Commun, 1999, 257( 1 ): 79-83.

二级参考文献5

共引文献1

同被引文献6

  • 1Winkler G, Cseh K. Molecular mechanisms and correlations of insulin resistance, obesity, and type 2 diabetes mellitus[J].Orv Hetil, 2009, 150 (17) : 771-780.
  • 2Miner JL. The adipocyte as endocrine cell[J]. J Anim Sci, 2004, 82 ( 4 ) : 935-940.
  • 3Kadoglou NP, Sailer N, Moumtzouoglou A, et al. Visfatin ( nampt ) and ghrelin as novel markers of carotid atherosclerosis in patients with type 2 diabetes[J]. Exp Clin Endocrinol Diabetes, 2010, 118 (2) : 75-80.
  • 4Wan Y, Evans RM. Rosiglitazone activation of PPARgamma suppresses fractalkine signaling[J]. J Mol Endocrinol, 2010, 44 (2) : 135-142.
  • 5De Pauw A, Tejerina S, Raes M, et al. Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations[J]. Am J Pathol, 2009, 175 ( 3 ) : 927-939.
  • 6何芸,赵强,邹筱冬,吴同果.高血压病患者血清脂联素水平与左心室几何构型的关系[J].国际医药卫生导报,2011,17(11):1299-1302. 被引量:4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部